About Company
- Legal Name: Beijing Kawin Technology Share-Holding Co.,Ltd
- Registered country: China
- Address: No.6 Rongjing East Street, BDA, Beijing, China, Beijing
- Number of employees: 500 - 999
Description:
Focused on viral and immune diseases, Kawin offers mature products built on its specialty in interferon strain management to EP standards, and provides product licensing opportunities including a portfolio of glycyrrhizin products used in dermatology and hepatology, with transfer of interferon and G-CSF (both conventional and pegylated) open to discussion.
Business Activities
Biopharmaceutical Products
API Manufacturer
Biopharmaceutical Services
API Manufacturer
ATC (Anatomical Therapeutic Chemical) Classification
API Manufacturer
Sales Markets
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Western Asia: United Arab Emirates, Armenia, Azerbaijan, Bahrain
Key Products/Services
Our Products & Services
Certifications
Proofs
CPHI & PMEC China 2026
06/2026 – 06/2026
CPHI & PMEC China 2026
Ratings
(0)
(0)
(0)
(0)
(0)
Comments
Filters:
Sort by:
No comments available.
Leave your rating & comment